Artificial Intelligence & Prostate Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

October 10, 2023

Study Completion Date

December 31, 2024

Conditions
Prostate Cancer
Interventions
DEVICE

Quantib prostate (Quantib B.V. Rotterdam, The Netherlands) software

Quantib Prostate is an AI-driven solution that provides an intuitive workflow for assessment of prostate MRI. The product integrates essential prostate MRI reading features into one workflow making it easy for the user to read, assess and report each patient case from within the same software interface. With automatic forwarding in place, the software preprocesses the MRI right after scanning. This allows the user to access calculations and analysis immediately when they open the software interface. Thanks to these features, the professional may experience an accelerated workflow, making it easier to manage their heavier workload.

Trial Locations (1)

20132

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER